Metabolic myopthies

Reading File

Finding Sources

Searching PubMed

"metabolic myopathy" diagnosis management

Finding Sources

Reading File

Finding Sources

Reading File

Searching Images

metabolic myopathy ragged red fibers mitochondrial glycogen storage muscle biopsy

Now I have comprehensive material. Let me compile a thorough response.

Metabolic Myopathies

Metabolic myopathies are a group of hereditary (and occasionally acquired) muscle disorders in which defects in biochemical pathways that generate ATP lead to exercise intolerance, muscle pain, contractures, and myoglobinuria. They are classically divided into three major categories: disorders of carbohydrate metabolism, disorders of lipid metabolism, and disorders of mitochondrial function.

Core Pathophysiology

The fundamental defect in all metabolic myopathies is impairment of ATP synthesis in skeletal muscle. Normally, muscle has safety mechanisms that prevent exercise to the point of destruction. In metabolic myopathies, these mechanisms fail:

Forced exercise → muscle pain → contracture (electrically silent, unlike a cramp)
Continued exertion → rhabdomyolysis → myoglobinuria → risk of acute tubular necrosis
Symptoms span: fatigue → muscle pain → contractures → myoglobinuria (escalating severity)

"In the metabolic muscle diseases, maintenance of ATP levels is impaired, and the protective mechanism that functions in the normal person is absent." — Bradley and Daroff's Neurology in Clinical Practice

1. Disorders of Carbohydrate Metabolism

Glycogen provides the dominant fuel in the early (first ~20 min) phase of exercise. Defects in glycolysis cause symptoms that arise rapidly with intense, short-duration effort.

McArdle Disease (Myophosphorylase Deficiency — Type V GSD)

Gene/locus: PYGM, chromosome 11q13; autosomal recessive
Defect: Absence of myophosphorylase → muscle cannot liberate glucose from glycogen
Clinical: Exercise intolerance, muscle pain, and contractures within minutes of vigorous activity; classic "second-wind" phenomenon (symptoms improve after ~8–10 min as the body switches to circulating metabolites)
Lab: CK elevated (markedly during/after attacks); no rise in venous lactate after ischemic forearm exercise (flat lactate test)
Biopsy: Subsarcolemmal accumulation of glycogen; absent myophosphorylase on histochemistry
Treatment: Aerobic training (promotes second wind); pre-exercise sucrose supplementation

Pompe Disease (Acid Maltase Deficiency — Type II GSD)

Gene/locus: GAA; autosomal recessive
Defect: Deficiency of lysosomal acid α-glucosidase → glycogen accumulates in lysosomes → lysosomal rupture → myofiber destruction
Three clinical forms:

Form	Onset	Features
Infantile (classic)	< 6 months	Hypotonia, cardiomegaly, macroglossia, hepatomegaly; fatal by age 2 (cardiorespiratory failure)
Juvenile	First decade	Progressive proximal weakness, respiratory involvement; resembles Duchenne or LGMD
Adult-onset	3rd–4th decade	Proximal > distal weakness; predominant respiratory muscle involvement (diaphragm); resembles polymyositis or LGMD

Treatment: Enzyme replacement therapy (ERT) with alglucosidase alfa; newer cipaglucosidase alfa + miglustat (chaperone) has shown improved outcomes in late-onset Pompe disease (meta-analysis, PMID 41757410)

Other Glycolytic Enzyme Deficiencies

Enzyme	Key Features
PFK deficiency (Type VII — Tarui disease)	Clinically identical to McArdle; no second-wind; mild hemolytic anemia (red cells also lack M-subunit of PFK); nausea/vomiting with attacks
Phosphoglycerate kinase deficiency	X-linked (Xq13); may include hemolytic anemia, intellectual disability, seizures
Phosphoglycerate mutase deficiency	Muscle pain + myoglobinuria; elevated uric acid
Lactate dehydrogenase deficiency	High CK but low LDH (discrepancy); pyruvate rises after exercise but lactate does not
β-Enolase deficiency	Exercise intolerance, myalgia, episodic hyperCKemia

2. Disorders of Lipid Metabolism

Fatty acids become the dominant fuel after ~20–30 minutes of sustained aerobic exercise. Defects here cause symptoms during prolonged, endurance-type exertion — not brief sprints.

Carnitine Palmitoyltransferase II (CPT-II) Deficiency

Most common disorder of lipid metabolism causing episodic muscle disease
Mechanism: CPT-I (outer mitochondrial membrane) links carnitine to long-chain fatty acids; CPT-II (inner membrane) unlinks it. Deficiency → fatty acids cannot enter mitochondria
Clinical: Myoglobinuria after prolonged exercise (mountain climbing, tennis); attacks worsened by fasting, infection, or cold; patients often muscular (prefer sprinting/weightlifting)
Lab: CK normal between attacks; ischemic forearm exercise test is normal (glycolytic pathway intact); RER remains near 1.0 even at rest
Biopsy: Normal between attacks
Treatment: Avoid prolonged fasting + strenuous exercise; glucose supplementation during exercise; admit for forced alkaline diuresis if myoglobinuria occurs

Other Lipid Storage Disorders

Primary carnitine deficiency: Cardiomyopathy + proximal myopathy; treated with oral carnitine
Neutral lipid storage disease (NLSD):
- NLSD with myopathy (NLSD-M): Due to mutations in ATGL (adipose triglyceride lipase) — progressive myopathy
- NLSD with ichthyosis (NLSD-I / Chanarin-Dorfman syndrome): Mutations in CGI-58 (co-activator of ATGL); associated with skin lesions

3. Mitochondrial Myopathies

The most complex category, with dual (nuclear + mitochondrial) genetic control. Mitochondrial mutations show maternal inheritance and heteroplasmy (variable disease expression based on threshold of mutant mtDNA).

Pathophysiology

Both fatty acids and glycolysis converge on acetyl-CoA → Krebs cycle → electron transport chain (ETC) → ATP
mtDNA encodes 13 ETC proteins + 22 tRNAs + 2 rRNAs; rest are nuclear-encoded
When mitochondrial function is impaired, resting muscle may require fully activated oxidative metabolism → symptoms even at rest; anaerobic backup → lactic acidosis

Morphology

Ragged red fibers (RRF): Pathognomonic — subsarcolemmal accumulation of abnormal mitochondria; seen on modified Gomori trichrome stain (red blotches)
COX-negative / SDH-positive fibers on sequential histochemistry
Electron microscopy: Structurally abnormal mitochondria with paracrystalline inclusions

Ragged red fibers — modified Gomori trichrome showing subsarcolemmal mitochondrial proliferation (RRF)

Major Syndromes

Syndrome	Full Name	Key Features
MELAS	Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes	Most common (m.3243A>G in tRNA^Leu); proximal weakness + stroke-like episodes (especially posterior cortex), dementia, lactic acidosis, RRF
MERRF	Myoclonic Epilepsy with Ragged Red Fibers	Myoclonus + epilepsy + ataxia + RRF; m.8344A>G
CPEO/KSS	Chronic Progressive External Ophthalmoplegia / Kearns-Sayre Syndrome	Bilateral ptosis + ophthalmoplegia; KSS also has cardiac conduction defects, retinitis pigmentosa, cerebellar ataxia (onset < 20 yrs)
MILS	Maternally Inherited Leigh Syndrome	Subacute necrotizing encephalomyelopathy; regression, brainstem signs
NARP	Neuropathy, Ataxia, Retinitis Pigmentosa	m.8993T>G; ataxia + retinitis pigmentosa
MLASA	Mitochondrial Myopathy, Lactic Acidosis, Sideroblastic Anemia	Rare; caused by mutations in PUS1 or YARS2

Clinical Features of Mitochondrial Myopathies (General)

Onset often in childhood; exercise → heavy limbs, muscle aches, nausea, breathlessness
Fixed proximal weakness (may be sole presentation)
Elevated resting lactate/pyruvate (L:P ratio >20 suggests ETC defect)
Multi-system involvement: CNS, heart (cardiomyopathy, arrhythmia), eyes, ears (sensorineural deafness), endocrine (DM)
Short stature, ptosis, ophthalmoplegia are common clues

4. Disorder of Nucleotide Metabolism

Myoadenylate Deaminase (AMPDA) Deficiency

Affects ~1–2% of the population (most are asymptomatic)
Enzyme converts AMP → IMP + ammonia; supports ATP recycling during exercise
Forearm exercise test: Normal lactate rise but no ammonia production (diagnostic)
Clinical significance debated — poor correlation between enzyme defect and symptoms

Diagnostic Approach

Investigations

Test	Utility
Serum CK	Elevated during/after attacks; can be normal between attacks in CPT deficiency
Ischemic forearm exercise test	Glycolytic disorders: no lactate rise; AMPDA deficiency: no ammonia rise
Serum lactate/pyruvate	Elevated at rest or with minimal exercise in mitochondrial disorders
Urine myoglobin	Present during rhabdomyolytic attacks
EMG	Myopathic pattern; contractures are electrically silent
Muscle biopsy	Gold standard; histochemistry (PAS for glycogen, oil red O for lipid, Gomori trichrome for RRF, COX/SDH staining)
Enzyme assay (leukocytes/muscle)	Confirmatory for specific enzymatic defects
Genetic panel	Next-generation sequencing; mtDNA analysis for mitochondrial disorders

Pattern Recognition

Feature	Glycolytic Disorder	Lipid Disorder	Mitochondrial
Symptom trigger	Brief intense exercise	Prolonged aerobic exercise / fasting	Variable; rest → exertion
Second wind	Yes (McArdle)	No	No
Lactate with exercise	No rise (flat)	Normal	High at rest/low exercise
Biopsy finding	Glycogen accumulation	Lipid vacuoles	Ragged red fibers
Myoglobinuria	Common (McArdle, PFK)	Severe (CPT-II)	Occasional
Multi-system	Rare	Rare	Very common

Management Summary

Glycolytic disorders: Aerobic exercise training; sucrose supplementation pre-exercise (McArdle); avoid ischemia
Lipid disorders: Avoid prolonged fasting; glucose supplementation; medium-chain triglyceride (MCT) diet in some; aggressive hydration if myoglobinuria
Pompe disease: ERT (alglucosidase alfa); newer cipaglucosidase alfa + miglustat shows improved efficacy
Mitochondrial: Largely supportive; CoQ10 supplementation (in CoQ10 deficiencies); manage complications (pacemaker for KSS, insulin for mitochondrial DM); avoid mitochondrial toxins (valproate, metformin in severe disease)
All: Monitor renal function during myoglobinuric attacks; genetic counseling

Sources:

Bradley and Daroff's Neurology in Clinical Practice, Chapters on Metabolic Myopathies
Robbins, Cotran & Kumar Pathologic Basis of Disease, Diseases of Lipid or Glycogen Metabolism + Mitochondrial Myopathies
Robbins & Kumar Basic Pathology, Channelopathies, Metabolic Myopathies, and Mitochondrial Myopathies
Recent meta-analysis on cipaglucosidase alfa + miglustat vs. alglucosidase alfa in late-onset Pompe disease [PMID: 41757410]

Explain forearm test and ammonia test

Finding Sources

Reading File

Now I have everything needed for a thorough explanation.

Forearm Exercise Test (Non-Ischemic) & Ammonia Test

Background — Why This Test?

During brief, intense exercise, the forearm muscles rely almost entirely on anaerobic glycolysis (muscle glycogen → glucose → lactate). Two metabolic byproducts are generated in parallel:

Lactate — end product of glycolysis via lactate dehydrogenase
Ammonia (+ hypoxanthine, inosine) — produced via the purine nucleotide cycle:
- When ATP is consumed rapidly → ADP → AMP
- Adenylate kinase: 2 ADP → ATP + AMP
- AMP deaminase (AMPDA): AMP → IMP + NH₃ (ammonia)

Both pathways are activated simultaneously in normal muscle under anaerobic stress. This parallel relationship is the basis of the test.

The Test — Protocol

Classic (Ischemic) Forearm Exercise Test

A blood pressure cuff is inflated above systolic pressure on the upper arm (creating ischemia)
The patient grips a dynamometer repetitively for 1 minute at maximum effort
The cuff is released; venous blood is drawn from the antecubital vein at baseline, then at 1, 3, 5, and 10 minutes post-exercise

Problem: Ischemic testing carries a risk of rhabdomyolysis in patients with glycolytic enzyme defects — the very patients being tested. It is now largely abandoned.

Non-Ischemic (Non-Occlusive) Forearm Exercise Test — Current Standard

Same protocol but without the blood pressure cuff
Exercise must be sufficiently strenuous that the forearm muscle outpaces blood-borne substrate delivery (effectively self-ischemic through high workload)
Easy to perform, cost-effective, high sensitivity
Venous samples drawn at the same intervals for lactate and ammonia

Normal Response

Metabolite	Expected Rise
Lactate	≥ 3× baseline (typically rises 3–5 fold)
Ammonia	≥ 3× baseline

Both rise together — this confirms:

Glycolytic pathway is intact (lactate rises)
Purine nucleotide cycle is intact (ammonia rises)

Interpretation of Abnormal Results

1. Glycolytic / Glycogenolytic Defect (e.g., McArdle disease, PFK deficiency, other glycolytic enzyme defects)

Lactate	Ammonia
Flat — no rise	Normal or exaggerated rise

Reason: Muscle cannot convert glycogen/glucose → pyruvate → lactate (glycolysis blocked). However, the purine nucleotide cycle is intact, so AMP is still deaminated to NH₃. In fact, because ATP depletion is excessive (glycolysis cannot regenerate it), ammonia may rise even more than normal.

"Patients with certain defects in the glycolytic pathways produce normal to excessive amounts of ammonia and hypoxanthine, but no lactate." — Bradley and Daroff's Neurology

Key point: In McArdle disease, exercise causes a painful electrically silent contracture — this distinguishes it from a cramp (which shows electrical activity on EMG).

2. Myoadenylate Deaminase (AMPDA) Deficiency

Lactate	Ammonia
Normal rise	Flat — no rise

Reason: The purine nucleotide cycle is broken at the AMP → IMP step, so no ammonia is produced. Glycolysis is entirely intact, so lactate rises normally.

This is the "ammonia test" — specifically diagnosing AMPDA deficiency by showing absent ammonia response with preserved lactate production.

3. Poor Effort / Non-Cooperative Patient

Lactate	Ammonia
No rise	No rise

Both are flat because the patient simply did not work hard enough to exceed the blood supply. This must be distinguished from a true metabolic defect — repeating the test with supervised effort is necessary.

4. Mitochondrial Myopathy

Lactate	Ammonia/Hypoxanthine
Excessive rise at rest / low workload	Excessive rise

Both are elevated disproportionately because mitochondrial failure forces excessive reliance on anaerobic metabolism even at low workloads — lactate piles up because the ETC cannot re-oxidize NADH efficiently.

Summary Table

Condition	Lactate	Ammonia	Interpretation
Normal	↑↑	↑↑	Both pathways intact
McArdle / PFK / glycolytic defect	Flat	↑↑ (normal or high)	Glycolysis blocked; purine cycle intact
AMPDA deficiency	↑↑ (normal)	Flat	Purine cycle blocked; glycolysis intact
Poor effort	Flat	Flat	Neither pathway activated (no real exercise)
Mitochondrial myopathy	↑↑↑ (excessive)	↑↑↑ (excessive)	Anaerobic overload due to ETC failure

Clinical Pearls

The test targets forearm muscle specifically because it is anatomically convenient for venous sampling and creates a largely closed, self-contained muscular system during gripping exercise
In CPT-II deficiency (lipid metabolism defect), the forearm test is normal — fatty acids aren't used in brief, intense exercise; symptoms only arise after prolonged aerobic effort
The test is a screening tool — abnormal results require confirmation with muscle biopsy, enzyme assay, or genetic testing
Forearm test is now largely replaced by genetic panel testing in most centers where molecular diagnostics are available, but it remains useful when targeted, inexpensive, and rapid screening is needed

Sources:

Bradley and Daroff's Neurology in Clinical Practice, Exercise Testing
Harrison's Principles of Internal Medicine 22E, Glycogen Storage and Glycolytic Defects
Harrison's Principles of Internal Medicine 22E, Muscle Glycogen Storage Diseases

Approach to say in viva clinically for recurrent weakness chanalopathy vs myopathy vs nmj and also discuss hypokalemic vs hyperkalemic vs thyrotoxicosis vs Anderson Tamil vs mac ardle vs cpt2 vs mitochondrial clinically

Finding Sources

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

This is a shared conversation. Sign in to Orris to start your own chat.